Oligonucleotide Synthesis Market- Global Industry Analysis and Forecast (2022-2029)

Oligonucleotide Synthesis Market was valued at US$ 5.00 Bn in 2021 and is expected to reach 15.18 Bn by 2029, at a CAGR of 14.87% during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region. Oligonucleotide Synthesis Market To know about the Research Methodology :- Request Free Sample Report

Oligonucleotide Synthesis Market Dynamics:

The oligonucleotide synthesis market has found major development in the recent years and is anticipated to grow tremendously during the forecast period. Oligonucleotides are short sections of nucleic acids that are united utilizing enzyme chemistry and genetic engineering. These are utilized for diagnostics, therapeutic, and in addition industrial and academic. Oligonucleotides synthesis takes place technologically to give services to different end-users or independently by means of DNA synthesizers for self-utilization. The global market for oligonucleotide synthesis may also face a restriction in its growth due to the lack of available resources. The oligonucleotide synthesis market is expected to witness limitations in the availability of funding for research in academic laboratories, which may hamper market revenue growth. Along with this, there are also a restricted number of market players existing in some regions and a shortage of skilled personnel. These factors may hinder the growth of research activities.

Oligonucleotide Synthesis Market Segment Analysis:

The synthesized oligos segment held the largest share of the market in 2021 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the growing applications of synthesized oligos in therapeutics, research, and diagnostics. The biotechnology & Pharmaceutical Companies segment is expected to lead the market for oligonucleotide synthesis. Pharmaceutical industries and biotechnology companies are focused on looking for alternative approaches for disease treatment. As a result, these companies are making major use of oligonucleotides, as it offers an effective mode of action for the treatment of several indications at comparatively lower development costs.

Oligonucleotide Synthesis Market Regional Insights:

North America is expected to hold the largest market size for the oligonucleotide synthesis market globally. The Asian market size is expected to grow at the highest CAGR, mainly owing to the rising accessibility of synthesized oligos, along with a rise in R&D funding and activities in the region. Japan and China are considered the most attractive markets with respect to growth opportunities present in these countries. Additionally, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus helping its growth. Recent developments in the market for oligonucleotide synthesis: In March 2018, Danaher Corporation publicized that they have acquired Integrated DNA Technologies. The main of the acquisition is to increase their business in the genomics market and with IDT to develop critical diagnostic tests and potential life-saving therapies. They want to provide consumers highest standards of quality, service, and technical expertise. In February 2021, Integrated DNA Technologies announced that they have acquired GeneWorks Pty Ltd. The main goal of the acquisition is to expand its business in the Asia- Pacific regions. They want to provide high-quality products and services to the scientist around the world. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Oligonucleotide Synthesis Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence.

Oligonucleotide Synthesis Market, Key Highlights:

• Global Oligonucleotide Synthesis Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oligonucleotide Synthesis Market • Global Oligonucleotide Synthesis Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Oligonucleotide Synthesis Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Oligonucleotide Synthesis Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Oligonucleotide Synthesis Market are also profiled.

Oligonucleotide Synthesis Market Report Scope : Inquire before buying

Global Lead Acid Battery Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 5.00 Bn.
Forecast Period 2022 to 2029 CAGR: 14.87% Market Size in 2029: US $ 15.18 Bn.
Segments Covered: by Product Type • Reagents & Consumables • Equipment • Synthesized oligonucleotides • DNA oligonucleotides • RNA oligonucleotides • Others
by Application • Research • Polymerase Chain Reaction (PCR) • Next Generation Sequencing • Therapeutics • Antisense Oligonucleotides • Nucleic Acid Aptamers • Diagnostics • Others

Oligonucleotide Synthesis Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Oligonucleotide Synthesis Market, Key Players:

• Gilent Technologies • Adtbio • Bioautomation • Bio-Synthesis Inc. • Eurofins Genomics • Eurogentec • GE Healthcare • Genscript • Genedesign • Integrated DNA Technologies • LGC Biosearch Technologies • Merck KGaA • Nitto Denko Avecia • Thermo Fisher Scientific • Trilink Biotechnologies • Agilent Technologies, Inc. • Adtbio • Sarepta Therapeutics, Inc. (US). • Danaher Corporation • GeneDesign, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Oligonucleotide Synthesis Market? Ans: North America region held the highest share in 2021. 2. What is the growth rate of Global Oligonucleotide Synthesis Market? Ans: The Global Oligonucleotide Synthesis Market is expected to grow at a CAGR of 14.87% during forecast period 2022-2029. 3. What is scope of the Global Oligonucleotide Synthesis market report? Ans: Global Oligonucleotide Synthesis Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Oligonucleotide Synthesis market? Ans: The important key players in the Global Oligonucleotide Synthesis Market are – Gilent Technologies, Adtbio, Bioautomation, Bio-Synthesis Inc., Eurofins Genomics, Eurogentec, GE Healthcare, Genscript, Genedesign, Integrated DNA Technologies, LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia, Thermo Fisher Scientific, Trilink Biotechnologies, Agilent Technologies, Inc, Adtbio, Sarepta Therapeutics, Inc. (US), Danaher Corporation, GeneDesign, and Inc 5. What is the study period of this market? Ans: The Global Oligonucleotide Synthesis Market is studied from 2021 to 2029.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary : Global Oligonucleotide Synthesis Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Oligonucleotide Synthesis Market 5. Supply Side and Demand Side Indicators 6. Global Oligonucleotide Synthesis Market Analysis and Forecast 6.1. Global Oligonucleotide Synthesis Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 7.4. Global Oligonucleotide Synthesis Market Size (US$ Bn) Forecast, by Product Type 7.5. Global Oligonucleotide Synthesis Market Analysis, by Product Type 7.6. Global Oligonucleotide Synthesis Market Attractiveness Analysis, by Product Type 8. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Oligonucleotide Synthesis Market Value Share Analysis, by Application 8.4. Global Oligonucleotide Synthesis Market Size (US$ Bn) Forecast, by Application 8.5. Global Oligonucleotide Synthesis Market Analysis, by Application 8.6. Global Oligonucleotide Synthesis Market Attractiveness Analysis, by Application 9. Global Oligonucleotide Synthesis Market Analysis and Forecast, by End-users 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Oligonucleotide Synthesis Market Value Share Analysis, by End-users 9.4. Global Oligonucleotide Synthesis Market Size (US$ Bn) Forecast, by End-users 9.5. Global Oligonucleotide Synthesis Market Analysis, by End-users 9.6. Global Oligonucleotide Synthesis Market Attractiveness Analysis, by End-users 10. Global Oligonucleotide Synthesis Market Analysis, by Region 10.1. Global Oligonucleotide Synthesis Market Value Share Analysis, by Region 10.2. Global Oligonucleotide Synthesis Market Size (US$ Bn) Forecast, by Region 10.3. Global Oligonucleotide Synthesis Market Attractiveness Analysis, by Region 11. North America Oligonucleotide Synthesis Market Analysis 11.1. Key Findings 11.2. North America Oligonucleotide Synthesis Market Overview 11.3. North America Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 11.4. North America Oligonucleotide Synthesis Market Forecast, by Product Type 11.4.1. Reagents & Consumables 11.4.2. Equipment 11.4.3. Synthesized oligonucleotides 11.4.4. DNA oligonucleotides 11.4.5. RNA oligonucleotides 11.4.6. Others 11.5. North America Oligonucleotide Synthesis Market Value Share Analysis, by Application 11.6. North America Oligonucleotide Synthesis Market Forecast, by Application 11.6.1. Research 11.6.2. Polymerase Chain Reaction (PCR) 11.6.3. Next Generation Sequencing 11.6.4. Therapeutics 11.6.5. Antisense Oligonucleotides 11.6.6. Nucleic Acid Aptamers 11.6.7. Diagnostics 11.6.8. Others 11.7. North America Oligonucleotide Synthesis Market Value Share Analysis, by End-users 11.8. North America Oligonucleotide Synthesis Market Forecast, by End-users 11.8.1. Biotechnology & Pharmaceutical Companies 11.8.2. Research Institutes 11.8.3. Diagnostic Laboratories 11.9. North America Oligonucleotide Synthesis Market Value Share Analysis, by Country 11.10. North America Oligonucleotide Synthesis Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Oligonucleotide Synthesis Market Analysis, by Country 11.12. U.S. Oligonucleotide Synthesis Market Forecast, by Product Type 11.12.1. Reagents & Consumables 11.12.2. Equipment 11.12.3. Synthesized oligonucleotides 11.12.4. DNA oligonucleotides 11.12.5. RNA oligonucleotides 11.12.6. Others 11.13. U.S. Oligonucleotide Synthesis Market Forecast, by Application 11.13.1. Research 11.13.2. Polymerase Chain Reaction (PCR) 11.13.3. Next Generation Sequencing 11.13.4. Therapeutics 11.13.5. Antisense Oligonucleotides 11.13.6. Nucleic Acid Aptamers 11.13.7. Diagnostics 11.13.8. Others 11.14. U.S. Oligonucleotide Synthesis Market Forecast, by End-users 11.14.1. Biotechnology & Pharmaceutical Companies 11.14.2. Research Institutes 11.14.3. Diagnostic Laboratories 11.15. Canada Oligonucleotide Synthesis Market Forecast, by Product Type 11.15.1. Reagents & Consumables 11.15.2. Equipment 11.15.3. Synthesized oligonucleotides 11.15.4. DNA oligonucleotides 11.15.5. RNA oligonucleotides 11.15.6. Others 11.16. Steel Canada Oligonucleotide Synthesis Market Forecast, by Application 11.16.1. Research 11.16.2. Polymerase Chain Reaction (PCR) 11.16.3. Next Generation Sequencing 11.16.4. Therapeutics 11.16.5. Antisense Oligonucleotides 11.16.6. Nucleic Acid Aptamers 11.16.7. Diagnostics 11.16.8. Others 11.17. Canada Oligonucleotide Synthesis Market Forecast, by End-users 11.17.1. Biotechnology & Pharmaceutical Companies 11.17.2. Research Institutes 11.17.3. Diagnostic Laboratories 11.18. North America Oligonucleotide Synthesis Market Attractiveness Analysis 11.18.1. By Product Type 11.18.2. By Application 11.18.3. By End-users 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Oligonucleotide Synthesis Market Analysis 12.1. Key Findings 12.2. Europe Oligonucleotide Synthesis Market Overview 12.3. Europe Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 12.4. Europe Oligonucleotide Synthesis Market Forecast, by Product Type 12.4.1. Reagents & Consumables 12.4.2. Equipment 12.4.3. Synthesized oligonucleotides 12.4.4. DNA oligonucleotides 12.4.5. RNA oligonucleotides 12.4.6. Others 12.5. Europe Oligonucleotide Synthesis Market Value Share Analysis, by Application 12.6. Europe Oligonucleotide Synthesis Market Forecast, by Application 12.6.1. Research 12.6.2. Polymerase Chain Reaction (PCR) 12.6.3. Next Generation Sequencing 12.6.4. Therapeutics 12.6.5. Antisense Oligonucleotides 12.6.6. Nucleic Acid Aptamers 12.6.7. Diagnostics 12.6.8. Others 12.7. Europe Oligonucleotide Synthesis Market Value Share Analysis, by End-users 12.8. Europe Oligonucleotide Synthesis Market Forecast, by End-users 12.8.1. Biotechnology & Pharmaceutical Companies 12.8.2. Research Institutes 12.8.3. Diagnostic Laboratories 12.9. Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country 12.10. Europe Oligonucleotide Synthesis Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Oligonucleotide Synthesis Market Analysis, by Country 12.12. Germany Oligonucleotide Synthesis Market Forecast, by Product Type 12.12.1. Reagents & Consumables 12.12.2. Equipment 12.12.3. Synthesized oligonucleotides 12.12.4. DNA oligonucleotides 12.12.5. RNA oligonucleotides 12.12.6. Others 12.13. Germany Oligonucleotide Synthesis Market Forecast, by Application 12.13.1. Research 12.13.2. Polymerase Chain Reaction (PCR) 12.13.3. Next Generation Sequencing 12.13.4. Therapeutics 12.13.5. Antisense Oligonucleotides 12.13.6. Nucleic Acid Aptamers 12.13.7. Diagnostics 12.13.8. Others 12.14. Germany Oligonucleotide Synthesis Market Forecast, by End-users 12.14.1. Biotechnology & Pharmaceutical Companies 12.14.2. Research Institutes 12.14.3. Diagnostic Laboratories 12.15. U.K. Oligonucleotide Synthesis Market Forecast, by Product Type 12.15.1. Reagents & Consumables 12.15.2. Equipment 12.15.3. Synthesized oligonucleotides 12.15.4. DNA oligonucleotides 12.15.5. RNA oligonucleotides 12.15.6. Others 12.16. U.K. Oligonucleotide Synthesis Market Forecast, by Application 12.16.1. Research 12.16.2. Polymerase Chain Reaction (PCR) 12.16.3. Next Generation Sequencing 12.16.4. Therapeutics 12.16.5. Antisense Oligonucleotides 12.16.6. Nucleic Acid Aptamers 12.16.7. Diagnostics 12.16.8. Others 12.17. U.K. Oligonucleotide Synthesis Market Forecast, by End-users 12.17.1. Biotechnology & Pharmaceutical Companies 12.17.2. Research Institutes 12.17.3. Diagnostic Laboratories 12.18. France Oligonucleotide Synthesis Market Forecast, by Product Type 12.18.1. Reagents & Consumables 12.18.2. Equipment 12.18.3. Synthesized oligonucleotides 12.18.4. DNA oligonucleotides 12.18.5. RNA oligonucleotides 12.18.6. Others 12.19. France Oligonucleotide Synthesis Market Forecast, by Application 12.19.1. Research 12.19.2. Polymerase Chain Reaction (PCR) 12.19.3. Next Generation Sequencing 12.19.4. Therapeutics 12.19.5. Antisense Oligonucleotides 12.19.6. Nucleic Acid Aptamers 12.19.7. Diagnostics 12.19.8. Others 12.20. France Oligonucleotide Synthesis Market Forecast, by End-users 12.20.1. Biotechnology & Pharmaceutical Companies 12.20.2. Research Institutes 12.20.3. Diagnostic Laboratories 12.21. Italy Oligonucleotide Synthesis Market Forecast, by Product Type 12.21.1. Reagents & Consumables 12.21.2. Equipment 12.21.3. Synthesized oligonucleotides 12.21.4. DNA oligonucleotides 12.21.5. RNA oligonucleotides 12.21.6. Others 12.22. Italy Oligonucleotide Synthesis Market Forecast, by Application 12.22.1. Research 12.22.2. Polymerase Chain Reaction (PCR) 12.22.3. Next Generation Sequencing 12.22.4. Therapeutics 12.22.5. Antisense Oligonucleotides 12.22.6. Nucleic Acid Aptamers 12.22.7. Diagnostics 12.22.8. Others 12.23. Italy Oligonucleotide Synthesis Market Forecast, by End-users 12.23.1. Biotechnology & Pharmaceutical Companies 12.23.2. Research Institutes 12.23.3. Diagnostic Laboratories 12.24. Spain Oligonucleotide Synthesis Market Forecast, by Product Type 12.24.1. Reagents & Consumables 12.24.2. Equipment 12.24.3. Synthesized oligonucleotides 12.24.4. DNA oligonucleotides 12.24.5. RNA oligonucleotides 12.24.6. Others 12.25. Spain Oligonucleotide Synthesis Market Forecast, by Application 12.25.1. Research 12.25.2. Polymerase Chain Reaction (PCR) 12.25.3. Next Generation Sequencing 12.25.4. Therapeutics 12.25.5. Antisense Oligonucleotides 12.25.6. Nucleic Acid Aptamers 12.25.7. Diagnostics 12.25.8. Others 12.26. Spain Oligonucleotide Synthesis Market Forecast, by End-users 12.26.1. Biotechnology & Pharmaceutical Companies 12.26.2. Research Institutes 12.26.3. Diagnostic Laboratories 12.27. Rest of Europe Oligonucleotide Synthesis Market Forecast, by Product Type 12.27.1. Reagents & Consumables 12.27.2. Equipment 12.27.3. Synthesized oligonucleotides 12.27.4. DNA oligonucleotides 12.27.5. RNA oligonucleotides 12.27.6. Others 12.28. Rest of Europe Oligonucleotide Synthesis Market Forecast, by Application 12.28.1. Research 12.28.2. Polymerase Chain Reaction (PCR) 12.28.3. Next Generation Sequencing 12.28.4. Therapeutics 12.28.5. Antisense Oligonucleotides 12.28.6. Nucleic Acid Aptamers 12.28.7. Diagnostics 12.28.8. Others 12.29. Rest Of Europe Oligonucleotide Synthesis Market Forecast, by End-users 12.29.1. Biotechnology & Pharmaceutical Companies 12.29.2. Research Institutes 12.29.3. Diagnostic Laboratories 12.30. Europe Oligonucleotide Synthesis Market Attractiveness Analysis 12.30.1. By Product Type 12.30.2. By Application 12.30.3. By End-users 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Oligonucleotide Synthesis Market Analysis 13.1. Key Findings 13.2. Asia Pacific Oligonucleotide Synthesis Market Overview 13.3. Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 13.4. Asia Pacific Oligonucleotide Synthesis Market Forecast, by Product Type 13.4.1. Reagents & Consumables 13.4.2. Equipment 13.4.3. Synthesized oligonucleotides 13.4.4. DNA oligonucleotides 13.4.5. RNA oligonucleotides 13.4.6. Others 13.5. Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Application 13.6. Asia Pacific Oligonucleotide Synthesis Market Forecast, by Application 13.6.1. Research 13.6.2. Polymerase Chain Reaction (PCR) 13.6.3. Next Generation Sequencing 13.6.4. Therapeutics 13.6.5. Antisense Oligonucleotides 13.6.6. Nucleic Acid Aptamers 13.6.7. Diagnostics 13.6.8. Others 13.7. Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by End-users 13.8. Asia Pacific Oligonucleotide Synthesis Market Forecast, by End-users 13.8.1. Biotechnology & Pharmaceutical Companies 13.8.2. Research Institutes 13.8.3. Diagnostic Laboratories 13.9. Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country 13.10. Asia Pacific Oligonucleotide Synthesis Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Oligonucleotide Synthesis Market Analysis, by Country 13.12. China Oligonucleotide Synthesis Market Forecast, by Product Type 13.12.1. Reagents & Consumables 13.12.2. Equipment 13.12.3. Synthesized oligonucleotides 13.12.4. DNA oligonucleotides 13.12.5. RNA oligonucleotides 13.12.6. Others 13.13. China Oligonucleotide Synthesis Market Forecast, by Application 13.13.1. Research 13.13.2. Polymerase Chain Reaction (PCR) 13.13.3. Next Generation Sequencing 13.13.4. Therapeutics 13.13.5. Antisense Oligonucleotides 13.13.6. Nucleic Acid Aptamers 13.13.7. Diagnostics 13.13.8. Others 13.14. China Oligonucleotide Synthesis Market Forecast, by End-users 13.14.1. Biotechnology & Pharmaceutical Companies 13.14.2. Research Institutes 13.14.3. Diagnostic Laboratories 13.15. India Oligonucleotide Synthesis Market Forecast, by Product Type 13.15.1. Reagents & Consumables 13.15.2. Equipment 13.15.3. Synthesized oligonucleotides 13.15.4. DNA oligonucleotides 13.15.5. RNA oligonucleotides 13.15.6. Others 13.16. India Oligonucleotide Synthesis Market Forecast, by Application 13.16.1. Research 13.16.2. Polymerase Chain Reaction (PCR) 13.16.3. Next Generation Sequencing 13.16.4. Therapeutics 13.16.5. Antisense Oligonucleotides 13.16.6. Nucleic Acid Aptamers 13.16.7. Diagnostics 13.16.8. Others 13.17. India Oligonucleotide Synthesis Market Forecast, by End-users 13.17.1. Biotechnology & Pharmaceutical Companies 13.17.2. Research Institutes 13.17.3. Diagnostic Laboratories 13.18. Japan Oligonucleotide Synthesis Market Forecast, by Product Type 13.18.1. Reagents & Consumables 13.18.2. Equipment 13.18.3. Synthesized oligonucleotides 13.18.4. DNA oligonucleotides 13.18.5. RNA oligonucleotides 13.18.6. Others 13.19. Japan Oligonucleotide Synthesis Market Forecast, by Application 13.19.1. Research 13.19.2. Polymerase Chain Reaction (PCR) 13.19.3. Next Generation Sequencing 13.19.4. Therapeutics 13.19.5. Antisense Oligonucleotides 13.19.6. Nucleic Acid Aptamers 13.19.7. Diagnostics 13.19.8. Others 13.20. Japan Oligonucleotide Synthesis Market Forecast, by End-users 13.20.1. Biotechnology & Pharmaceutical Companies 13.20.2. Research Institutes 13.20.3. Diagnostic Laboratories 13.21. ASEAN Oligonucleotide Synthesis Market Forecast, by Product Type 13.21.1. Reagents & Consumables 13.21.2. Equipment 13.21.3. Synthesized oligonucleotides 13.21.4. DNA oligonucleotides 13.21.5. RNA oligonucleotides 13.21.6. Otherss 13.22. ASEAN Oligonucleotide Synthesis Market Forecast, by Application 13.22.1. Research 13.22.2. Polymerase Chain Reaction (PCR) 13.22.3. Next Generation Sequencing 13.22.4. Therapeutics 13.22.5. Antisense Oligonucleotides 13.22.6. Nucleic Acid Aptamers 13.22.7. Diagnostics 13.22.8. Others 13.23. ASEAN Oligonucleotide Synthesis Market Forecast, by End-users 13.23.1. Biotechnology & Pharmaceutical Companies 13.23.2. Research Institutes 13.23.3. Diagnostic Laboratories 13.24. Rest of Asia Pacific Oligonucleotide Synthesis Market Forecast, by Product Type 13.24.1. Reagents & Consumables 13.24.2. Equipment 13.24.3. Synthesized oligonucleotides 13.24.4. DNA oligonucleotides 13.24.5. RNA oligonucleotides 13.24.6. Others 13.25. Rest of Asia Pacific Oligonucleotide Synthesis Market Forecast, by Application 13.25.1. Research 13.25.2. Polymerase Chain Reaction (PCR) 13.25.3. Next Generation Sequencing 13.25.4. Therapeutics 13.25.5. Antisense Oligonucleotides 13.25.6. Nucleic Acid Aptamers 13.25.7. Diagnostics 13.25.8. Others 13.26. Rest of Asia Pacific Oligonucleotide Synthesis Market Forecast, by End-users 13.26.1. Biotechnology & Pharmaceutical Companies 13.26.2. Research Institutes 13.26.3. Diagnostic Laboratories 13.27. Asia Pacific Oligonucleotide Synthesis Market Attractiveness Analysis 13.27.1. By Product Type 13.27.2. By Application 13.27.3. By End-users 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Oligonucleotide Synthesis Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Oligonucleotide Synthesis Market Overview 14.3. Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 14.4. Middle East & Africa Oligonucleotide Synthesis Market Forecast, by Product Type 14.4.1. Reagents & Consumables 14.4.2. Equipment 14.4.3. Synthesized oligonucleotides 14.4.4. DNA oligonucleotides 14.4.5. RNA oligonucleotides 14.4.6. Others 14.5. Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Application 14.6. Middle East & Africa Oligonucleotide Synthesis Market Forecast, by Application 14.6.1. Research 14.6.2. Polymerase Chain Reaction (PCR) 14.6.3. Next Generation Sequencing 14.6.4. Therapeutics 14.6.5. Antisense Oligonucleotides 14.6.6. Nucleic Acid Aptamers 14.6.7. Diagnostics 14.6.8. Others 14.7. Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by End-users 14.8. Middle East & Africa Oligonucleotide Synthesis Market Forecast, by End-users 14.8.1. Biotechnology & Pharmaceutical Companies 14.8.2. Research Institutes 14.8.3. Diagnostic Laboratories 14.9. Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country 14.10. Middle East & Africa Oligonucleotide Synthesis Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Oligonucleotide Synthesis Market Analysis, by Country 14.12. GCC Oligonucleotide Synthesis Market Forecast, by Product Type 14.12.1. Reagents & Consumables 14.12.2. Equipment 14.12.3. Synthesized oligonucleotides 14.12.4. DNA oligonucleotides 14.12.5. RNA oligonucleotides 14.12.6. Others 14.13. GCC Oligonucleotide Synthesis Market Forecast, by Application 14.13.1. Research 14.13.2. Polymerase Chain Reaction (PCR) 14.13.3. Next Generation Sequencing 14.13.4. Therapeutics 14.13.5. Antisense Oligonucleotides 14.13.6. Nucleic Acid Aptamers 14.13.7. Diagnostics 14.13.8. Others 14.14. GCC Oligonucleotide Synthesis Market Forecast, by End-users 14.14.1. Biotechnology & Pharmaceutical Companies 14.14.2. Research Institutes 14.14.3. Diagnostic Laboratories 14.15. South Africa Oligonucleotide Synthesis Market Forecast, by Product Type 14.15.1. Reagents & Consumables 14.15.2. Equipment 14.15.3. Synthesized oligonucleotides 14.15.4. DNA oligonucleotides 14.15.5. RNA oligonucleotides 14.15.6. Others 14.16. South Africa Oligonucleotide Synthesis Market Forecast, by Application 14.16.1. Research 14.16.2. Polymerase Chain Reaction (PCR) 14.16.3. Next Generation Sequencing 14.16.4. Therapeutics 14.16.5. Antisense Oligonucleotides 14.16.6. Nucleic Acid Aptamers 14.16.7. Diagnostics 14.16.8. Others 14.17. South Africa Oligonucleotide Synthesis Market Forecast, by End-users 14.17.1. Biotechnology & Pharmaceutical Companies 14.17.2. Research Institutes 14.17.3. Diagnostic Laboratories 14.18. Rest of Middle East & Africa Oligonucleotide Synthesis Market Forecast, by Product Type 14.18.1. Reagents & Consumables 14.18.2. Equipment 14.18.3. Synthesized oligonucleotides 14.18.4. DNA oligonucleotides 14.18.5. RNA oligonucleotides 14.18.6. Others 14.19. Rest of Middle East & Africa Oligonucleotide Synthesis Market Forecast, by Application 14.19.1. Research 14.19.2. Polymerase Chain Reaction (PCR) 14.19.3. Next Generation Sequencing 14.19.4. Therapeutics 14.19.5. Antisense Oligonucleotides 14.19.6. Nucleic Acid Aptamers 14.19.7. Diagnostics 14.19.8. Others 14.20. Rest of Middle East & Africa Oligonucleotide Synthesis Market Forecast, by End-users 14.20.1. Biotechnology & Pharmaceutical Companies 14.20.2. Research Institutes 14.20.3. Diagnostic Laboratories 14.21. Middle East & Africa Oligonucleotide Synthesis Market Attractiveness Analysis 14.21.1. By Product Type 14.21.2. By Application 14.21.3. By End-users 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Oligonucleotide Synthesis Market Analysis 15.1. Key Findings 15.2. South America Oligonucleotide Synthesis Market Overview 15.3. South America Oligonucleotide Synthesis Market Value Share Analysis, by Product Type 15.4. South America Oligonucleotide Synthesis Market Forecast, by Product Type 15.4.1. Reagents & Consumables 15.4.2. Equipment 15.4.3. Synthesized oligonucleotides 15.4.4. DNA oligonucleotides 15.4.5. RNA oligonucleotides 15.4.6. Others 15.5. South America Oligonucleotide Synthesis Market Value Share Analysis, by Application 15.6. South America Oligonucleotide Synthesis Market Forecast, by Application 15.6.1. Research 15.6.2. Polymerase Chain Reaction (PCR) 15.6.3. Next Generation Sequencing 15.6.4. Therapeutics 15.6.5. Antisense Oligonucleotides 15.6.6. Nucleic Acid Aptamers 15.6.7. Diagnostics 15.6.8. Others 15.7. South America Oligonucleotide Synthesis Market Value Share Analysis, by End-users 15.8. South America Oligonucleotide Synthesis Market Forecast, by End-users 15.8.1. Biotechnology & Pharmaceutical Companies 15.8.2. Research Institutes 15.8.3. Diagnostic Laboratories 15.9. South America Oligonucleotide Synthesis Market Value Share Analysis, by Country 15.10. South America Oligonucleotide Synthesis Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Oligonucleotide Synthesis Market Analysis, by Country 15.12. Brazil Oligonucleotide Synthesis Market Forecast, by Product Type 15.12.1. Reagents & Consumables 15.12.2. Equipment 15.12.3. Synthesized oligonucleotides 15.12.4. DNA oligonucleotides 15.12.5. RNA oligonucleotides 15.12.6. Others 15.13. Brazil Oligonucleotide Synthesis Market Forecast, by Application 15.13.1. Research 15.13.2. Polymerase Chain Reaction (PCR) 15.13.3. Next Generation Sequencing 15.13.4. Therapeutics 15.13.5. Antisense Oligonucleotides 15.13.6. Nucleic Acid Aptamers 15.13.7. Diagnostics 15.13.8. Others 15.14. Brazil Oligonucleotide Synthesis Market Forecast, by End-users 15.14.1. Biotechnology & Pharmaceutical Companies 15.14.2. Research Institutes 15.14.3. Diagnostic Laboratories 15.15. Mexico Oligonucleotide Synthesis Market Forecast, by Product Type 15.15.1. Reagents & Consumables 15.15.2. Equipment 15.15.3. Synthesized oligonucleotides 15.15.4. DNA oligonucleotides 15.15.5. RNA oligonucleotides 15.15.6. Others 15.16. Mexico Oligonucleotide Synthesis Market Forecast, by Application 15.16.1. Research 15.16.2. Polymerase Chain Reaction (PCR) 15.16.3. Next Generation Sequencing 15.16.4. Therapeutics 15.16.5. Antisense Oligonucleotides 15.16.6. Nucleic Acid Aptamers 15.16.7. Diagnostics 15.16.8. Others 15.17. Mexico Oligonucleotide Synthesis Market Forecast, by End-users 15.17.1. Biotechnology & Pharmaceutical Companies 15.17.2. Research Institutes 15.17.3. Diagnostic Laboratories 15.18. Rest of South America Oligonucleotide Synthesis Market Forecast, by Product Type 15.18.1. Reagents & Consumables 15.18.2. Equipment 15.18.3. Synthesized oligonucleotides 15.18.4. DNA oligonucleotides 15.18.5. RNA oligonucleotides 15.18.6. Others 15.19. Rest of South America Oligonucleotide Synthesis Market Forecast, by Application 15.19.1. Research 15.19.2. Polymerase Chain Reaction (PCR) 15.19.3. Next Generation Sequencing 15.19.4. Therapeutics 15.19.5. Antisense Oligonucleotides 15.19.6. Nucleic Acid Aptamers 15.19.7. Diagnostics 15.19.8. Others 15.20. Rest of South America Oligonucleotide Synthesis Market Forecast, by End-users 15.20.1. Biotechnology & Pharmaceutical Companies 15.20.2. Research Institutes 15.20.3. Diagnostic Laboratories 15.21. South America Oligonucleotide Synthesis Market Attractiveness Analysis 15.21.1. By Product Type 15.21.2. By Application 15.21.3. By End-users 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. gilent Technologies 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Adtbio 16.3.3. Bioautomation 16.3.4. Bio-Synthesis Inc. 16.3.5. Eurofins Genomics 16.3.6. Eurogentec 16.3.7. GE Healthcare 16.3.8. Genscript 16.3.9. Genedesign 16.3.10. Integrated DNA Technologies 16.3.11. LGC Biosearch Technologies 16.3.12. Merck KGaA 16.3.13. Nitto Denko Avecia 16.3.14. Thermo Fisher Scientific 16.3.15. Trilink Biotechnologies 16.3.16.Agilent Technologies, Inc. 16.3.17.Adtbio 16.3.18.Sarepta Therapeutics, Inc. (US). 16.3.19.Danaher Corporation 16.3.20.GeneDesign, Inc. 17. Primary Key Insights

About This Report

Report ID 31248
Category Material & Chemical
Published Date June 2022
Updated Date Sep 2022
Contact Us